Treatment of IgA nephropathy in children: a land without KDIGO guidance
Author:
- 14 February 2020
- journal article
- review article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 36 (3) , 491-496
Abstract
IgA nephropathy (IgAN) in children is no longer considered a rare and benign disease but a nephritis with different presentations and various outcomes. The decision to initiate a treatment and the therapeutic choice depend on the individual risk of progression. The Kidney Disease: Improving Global Outcomes (KDIGO) clinical guidelines in 2012 considered that the risk factors for progression of IgAN were similar in both children and adults and suggested in some conditions to follow the adult schedules. In 2017 a KDIGO Controversies Conference on management and treatment of glomerular diseases decided not to include an update in children with IgAN since the level of evidence of treatments in children was too scarce. Children can follow the indications for adults as far as the disease is similar in the various ages. This review is aimed at discussing why the KDIGO guidelines are poorly suitable to treat children with IgAN, and there is a need to develop new prediction models for progression of IgAN in children to guide selection of the cases to be treated. The identification of different risk levels in children with IgAN may personalize the choice of available drugs and support the use of new targeted therapies.Keywords
This publication has 41 references indexed in Scilit:
- Validation of the Oxford classification of IgA nephropathy for pediatric patients from ChinaBMC Nephrology, 2012
- Spontaneous remission in children with IgA nephropathyPediatric Nephrology, 2012
- NoticeKidney International Supplements, 2012
- Validity of the Oxford classification of IgA nephropathy in childrenPediatric Nephrology, 2011
- Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification)Nephrology Dialysis Transplantation, 2011
- The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adultsKidney International, 2010
- The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classificationKidney International, 2009
- Prognosis of Asymptomatic Hematuria and/or Proteinuria in MenNephron, 2002
- Frequency of renal diseases and clinical indications for renal biopsy in children (report of the Italian National Registry of Renal Biopsies in Children). Group of Renal Immunopathology of the Italian Society of Pediatric Nephrology and Group of Renal Immunopathology of the Italian Society of Nephrology.Nephrology Dialysis Transplantation, 1998
- Double-blind, controlled trial of short-term prednisone therapy in immunoglobulin A glomerulonephritisThe Journal of Pediatrics, 1992